Adagene completes enrollment in phase 2 trial of muzastotug
AI Summary
Adagene completed enrollment in a Phase 2 clinical trial of muzastotug. The headline does not specify the indication, trial size, or expected results timeline.
Related Articles
FG clears pension backlog, funds benefits until 2029
Punch Nigeria —
Maersk hit by fresh cyber breach
Splash247 Maritime —
Data Center Gas Plants to Lift US Power Emissions 10%, BNEF Says
Bloomberg —
What Do The Midterm Results Mean For Rates?
Seeking Alpha —
Union Minister opens ‘Promenade’ at Vizag port; lays foundation stone for ₹560 cr. projects
The Hindu —
Insulet: Rivals Are Building Patch Pumps, But Insulet Already Owns The Pharmacy Counter
Seeking Alpha —